Lipodystrophy clinical trials at UC Davis
1 in progress, 0 open to eligible people
Showing trials for
Daily Subcutaneous Metreleptin Treatment in Subjects With PL
Sorry, in progress, not accepting new patients
This is a Phase III, double-blind, placebo-controlled, safety and efficacy study of daily SC metreleptin in subjects with Partial Lipodystrophy.
Sacramento, California and other locations
Last updated: